3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neuroblastoma
4
Multiple Myeloma
2
Vaccinia
1
Transplant-Related Hematologic Malignancy
1
Recurrence
1
Prostatic Neoplasms
1
Oligodendroglioma
1
Neoplasms
1
Medulloblastoma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Kidney Neoplasms
1
Hodgkin Disease
1
Glioma
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Interventions
Temozolomide
5
Specimen Handling
2
Radiotherapy
2
Magnetic Resonance Spectroscopy
2
vocimagene amiretrorepvec
1
trametinib
1
dabrafenib
1
abexinostat
1
Vorinostat
1
Transurethral Resection of Bladder
1
Surgical Procedures, Operative
1
Standard of Care
1
Spinal Puncture
1
Restraint, Physical
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Protons
1
Proton Therapy
1
Practice Guidelines as Topic
1
Outcome Assessment, Health Care
1
Observational Studies as Topic
1
Ketoconazole
1
Irinotecan
1
Heart Rate
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Eflornithine
1
Diphtheria-Tetanus Vaccine
1
DNA
1
Craniotomy
1
Carmustine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Oligodendroglioma
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
90 days
×
Clear all
NCT06254326
2026-05-27
ADAGiO
University of Florida
Phase 1
Recruiting
12 enrolled